Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic <sup>18</sup>F-FDG PET/CT
Ron Epelbaum(University of Bern), Antonia Dimitrakopoulou‐Strauss(German Cancer Research Center), Ora Israel(Technion – Israel Institute of Technology), Riad Haddad(Carmel Medical Center), Ludwig G. Strauss(German Cancer Research Center), Alex Frenkel(Girls Incorporated), Natalia Sikorski(Haifa Medical Center)
Cited by 53
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279